Epistatic Variations in the Omicron Receptor Binding Domain Can Enhance Host Recognition: An In Silico Assessment and Prediction

J Phys Chem Lett. 2022 Sep 29;13(38):8808-8815. doi: 10.1021/acs.jpclett.2c02209. Epub 2022 Sep 15.

Abstract

The hypermutated receptor binding domain (RBD) of the Omicron (B.1.1.529) lineage exhibits a different binding interface with human angiotensin-converting enzyme 2 (ACE2) relative to that of the wild-type Wuhan Hu-1, yet how the altered interaction will affect viral evolution is largely unknown. Here, we used molecular dynamics simulation to characterize the binding features of the Omicron BA.1/hACE2 complex and used free energy perturbation calculations to assess the ongoing and putative variations. The complex reveals a substantial rearrangement of the interfacial hydrogen-bond network: R493 of RBD forms a dynamic electrostatic interaction with both E35 and D38 of hACE2, which prohibits the hydrogen bonds of R498-D38 and Y449-D38. Whereas most circulating mutations minimally affect RBD binding to hACE2, the charge-altering mutation R493Q attenuates the affinity by abolishing the electrostatic interaction. However, the potential variants H505Y or N417K/R493Q could restore and gain even greater binding affinities than BA.1 as a result of their optimized interaction network and epistasis effects.

MeSH terms

  • Angiotensin-Converting Enzyme 2*
  • Epistasis, Genetic
  • Humans
  • Hydrogen
  • Mutation
  • Peptidyl-Dipeptidase A / chemistry
  • Protein Binding
  • Severe acute respiratory syndrome-related coronavirus* / chemistry

Substances

  • Hydrogen
  • Peptidyl-Dipeptidase A
  • Angiotensin-Converting Enzyme 2